Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
European Journal of Clinical Pharmacology|November 19, 2020
The scientific basis of rational prescribing. A guide to precision clinical pharmacology based on the WHO 6-step methodG A Rongen, P Marquet, J M A van Gerven, et al.Journal of Psychopharmacology (Oxford, England)|April 27, 2004
The application of the principles of clinical drug development to pharmacological challenge tests of the serotonergic systemH J Gijsman, A F Cohen, J M A van GervenNederlands Tijdschrift Voor Geneeskunde|April 9, 2008
[New drugs; natalizumab]H van Bronswijk, E A Dubois, J M A van Gerven, et al.Annual Review of Pharmacology and Toxicology|October 9, 2014
The use of biomarkers in human pharmacology (Phase I) studiesA F Cohen, J Burggraaf, J M A van Gerven, et al.British Journal of Clinical Pharmacology|April 22, 2005
Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjectsG J H Dumont, S J de Visser, A F Cohen, et al.Journal of Psychopharmacology (Oxford, England)|July 23, 2003
REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteersB Rijnbeek, S J de Visser, K L Franson, et al.Journal of Psychopharmacology (Oxford, England)|August 4, 2009
Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjectsS L de Haas, R C Schoemaker, J M A van Gerven, et al.Journal of Psychopharmacology (Oxford, England)|July 21, 2004
Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patientsJ P van der Post, S J de Visser, R C Schoemaker, et al.Journal of Psychopharmacology (Oxford, England)|June 28, 2008
Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoidsA Strougo, L Zuurman, C Roy, et al.Journal of Psychopharmacology (Oxford, England)|April 27, 2004
No evidence of the usefulness of eye blinking as a marker for central dopaminergic activityJ van der Post, P P de Waal, M L de Kam, et al.Pageof 5